Adjuvant oral etoposide plus cisplatin (EoP) following sequential doxorubicin/cyclophosphamide (AC) and docetaxel (T) in early breast cancer patients with 4 or more positive lymph nodes (10 years follow-up)
| Autor: | Icli, Fikri, Akbulut, Hakan, Onur, Handan, Yalcin, Bulent, Demirkazık, Ahmet, Şenler, Filiz Çay |
|---|---|
| Zdroj: | In The Breast 2011 20(2):155-157 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect